We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+7.4%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$471B
AUM Growth
+$12.9B
Cap. Flow
-$11.2B
Cap. Flow %
-2.38%
Top 10 Hldgs %
12.86%
Holding
2,627
New
87
Increased
929
Reduced
999
Closed
89

Top Sells

Rank Stock Value
1
RTX icon
RTX Corp
RTX
+$1.73B
2
ECL icon
Ecolab
ECL
+$1.17B
3
CCI icon
Crown Castle
CCI
+$906M
4
PSX icon
Phillips 66
PSX
+$775M
5
GILD icon
Gilead Sciences
GILD
+$756M

Sector Composition

Rank Sector Weight
1 Healthcare 19.84%
2 Consumer Discretionary 13.93%
3 Financials 13.41%
4 Industrials 12.4%
5 Technology 9.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SSB icon
2051
SouthState Bank Corp
SSB
$10.8B
$386K ﹤0.01%
5,759
-1,400
-20% -$85.9K
ANDE icon
2052
Andersons Inc
ANDE
$2.22B
$385K ﹤0.01%
7,250
-1,300
-15% -$73.5K
SYNT
2053
DELISTED
Syntel Inc
SYNT
$385K ﹤0.01%
8,564
+2,944
+52% +$129K
STL
2054
DELISTED
Sterling Bancorp
STL
$385K ﹤0.01%
26,740
CYBX
2055
DELISTED
CYBERONICS INC
CYBX
$384K ﹤0.01%
6,890
+290
+4% +$15.2K
FFIN icon
2056
First Financial Bankshares
FFIN
$5.04B
$382K ﹤0.01%
25,576
SNCR
2057
DELISTED
Synchronoss Technologies
SNCR
$381K ﹤0.01%
1,011
ABMD
2058
DELISTED
Abiomed Inc
ABMD
$381K ﹤0.01%
10,000
SBY
2059
DELISTED
Silver Bay Realty Trust Corp.
SBY
$381K ﹤0.01%
22,983
+5,700
+33% +$94.3K
ALCO icon
2060
Alico
ALCO
$303M
$380K ﹤0.01%
7,600
LTC
2061
LTC Properties
LTC
$2.11B
$378K ﹤0.01%
8,750
-2,500
-22% -$102K
ELGX
2062
DELISTED
Endologix Inc
ELGX
$378K ﹤0.01%
2,470
NPKI
2063
NPK International
NPKI
$1.19B
$377K ﹤0.01%
39,500
FINL
2064
DELISTED
Finish Line
FINL
$376K ﹤0.01%
15,458
GLD icon
2065
SPDR Gold Trust
GLD
$142B
$375K ﹤0.01%
3,300
-3,950
-54% -$456K
BGS icon
2066
B&G Foods
BGS
$295M
$374K ﹤0.01%
12,500
FORR icon
2067
Forrester Research
FORR
$223M
$374K ﹤0.01%
9,500
MDC
2068
DELISTED
M.D.C. Holdings, Inc.
MDC
$374K ﹤0.01%
19,646
+18
+0.1% +$330
NTK
2069
DELISTED
NORTEK INC COM NEW (DE)
NTK
$374K ﹤0.01%
4,600
-1,700
-27% -$135K
GHL
2070
DELISTED
Greenhill & Co., Inc.
GHL
$372K ﹤0.01%
8,528
-3,100
-27% -$138K
CAL icon
2071
Caleres
CAL
$462M
$371K ﹤0.01%
11,530
RESI
2072
DELISTED
Front Yard Residential Corporation Common Stock
RESI
$370K ﹤0.01%
19,066
DMC
2073
Del Monte Corp
DMC
$1.44B
$369K ﹤0.01%
11,000
-7,000
-39% -$228K
KN icon
2074
Knowles
KN
$3.29B
$369K ﹤0.01%
15,650
-138,996
-90% -$2.88M
METR
2075
DELISTED
METRO BANCORP, INC COMMON STOCK
METR
$369K ﹤0.01%
14,237
-44,830
-76% -$1.1M

Similar funds

T. Rowe Price Associates's Q4 2014 Portfolio in Review

As of Q4 2014, T. Rowe Price Associates held 2,627 positions worth $471B, up 2.8% from $458B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

T. Rowe Price Associates's Q4 2014 filing shows 87 new, 929 increased, 999 reduced and 89 closed positions. Its largest new stake was Keysight: 17,553,953 shares worth $593M. The largest sale was RTX Corp, an estimated $1.73B.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Financials.

  • T. Rowe Price Associates's largest Q4 2014 buy was Keysight: 17,553,953 shares worth $593M.
  • T. Rowe Price Associates added most to Allergan plc in Q4 2014, an estimated $1.66B increase.
  • T. Rowe Price Associates's biggest Q4 2014 reduction was RTX Corp, cutting an estimated $1.73B.
  • T. Rowe Price Associates fully exited ATHLON ENERGY INC COM in Q4 2014, selling an estimated $499M.
  • T. Rowe Price Associates's ten largest holdings make up 13% of its $471B portfolio in Q4 2014.
  • T. Rowe Price Associates opened 87 new positions and closed 89 in Q4 2014.
  • T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $471B.

Based on T. Rowe Price Associates's 13F filing for Q4 2014, filed 13 Feb 2015.